19 assets in Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

Therapeutic assets addressing Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	National Cancer Institute (NCI)	P2	BB (64)
Adriamycin Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	B (60)
Azacitidine Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	National Cancer Institute (NCI)	P2	B (60)
Duvelisib Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	National Cancer Institute (NCI)	P2	CCC (55)
Camustine Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Cytarabine Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Etoposide Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Melphalan Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Prednisone Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Tazemetostat Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
(+)-Vincristine Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Eric Jacobsen, MD	P2	CCC (53)
Immunoglobulin G1, Anti-(Human/Macaca Fascicularis/Macaca Mulatta Killer Cell Lectin-Like Receptor Klrd1) (Human Monoclonal Dr-01 ?1-Chain), Disulfide With Human Monoclonal Dr-01 ?-Chain, Dimer Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Dren Bio	P1/2	CCC (48)
Pembrolizumab Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	City of Hope Medical Center	P1/2	CCC (48)
Pralatrexate Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	City of Hope Medical Center	P1/2	CCC (48)
Abatacept Recombinant Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Autologous Ccr4 Car T Cells Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Fludarabine Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Romidepsin Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	National Cancer Institute (NCI)	P1	CC (43)
Wu-Cart-007 Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma	Washington University School of Medicine	P1	CC (43)